Panagora Asset Management Inc Glaukos Corp Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$40.82 - $57.75 $166,423 - $235,446	-4,077 Reduced 19.37%	16,969 $741,000
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $6,089 - $7,603	-130 Reduced 0.61%	21,046 $1.12 Million
Q1 2022 May 12, 2022	BUY	$44.33 - $57.82 $5,762 - $7,516	130 Added 0.62%	21,176 $1.22 Million
Q4 2021 Feb 10, 2022	BUY	$40.27 - $56.99 $847,522 - $1.2 Million	21,046 New	21,046 $935,000
Q2 2020 Aug 12, 2020	SELL	$28.78 - $46.83 $43,285 - $70,432	-1,504 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$54.18 - $65.64 $81,486 - $98,722	1,504 New	1,504 $82,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.79B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.